ArticleFrontiers in oncology2026
A dual-prototype morphological topology evolution network for clinically oriented brain tumor MRI segmentation.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Automatic segmentation of brain tumor MRI images has important clinical significance for lesion localization, preoperative planning, and therapeutic efficacy assessment. To address the challenges of blurred boundaries, irregular morphology, and similar grayscale appearances between brain tumor regions and surrounding brain tissues, this study proposes a dual-prototype morphological evolution network. The proposed method adopts SegFormer as the backbone network and designs an adaptive dual-prototype representation module to enhance category discrimination through background and tumor prototypes. Meanwhile, a morphological evolution attention module is introduced to improve the model's perception of irregular boundaries and local structures through differentiable soft morphological operations. Experimental results show that the proposed method achieves an mIoU of 0.8479, an mDice of 0.8937, an mRecall of 0.9141, and an HD95 of 23.47 on the public brain tumor dataset. On the clinical brain tumor dataset, the corresponding values reach 0.7937, 0.8422, 0.8673, and 29.86, respectively. These results validate the effectiveness of the proposed method in brain tumor region recognition, boundary localization, and clinical auxiliary segmentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.